The Symptom Experience of Oncology Outpatients Has a Different Impact on Quality-of-Life Outcomes

Dorit Pud, Sarah Ben Ami, Bruce A. Cooper, Bradley E. Aouizerat, Dorit Cohen, Ruth Radiano, Pnina Naveh, Rivka Nikkhou-Abeles, Vered Hagbi, Orly Kachta, Aliza Yaffe, Christine Miaskowski

Research output: Contribution to journalArticle

Abstract

The aims of this replication study were to determine if subgroups of oncology outpatients receiving active treatment could be identified based on their experience with the symptoms of fatigue, sleep disturbance, depression, and pain; whether patients in these subgroups differed on selected demographic, disease, and treatment characteristics; and if patients in these subgroups differed on functional status and quality of life (QOL). A convenience sample of 228 oncology outpatients was recruited from seven outpatient settings in Israel. Patients completed a demographic questionnaire, a Karnofsky Performance Status score, the Multidimensional Quality of Life Scale-Cancer, the Lee Fatigue Scale, the General Sleep Disturbance Scale, the Center for Epidemiological Studies-Depression Scale, and a numeric rating scale of worst pain intensity. Cluster analysis was used to identify the patient subgroups based on their symptom experience. Four relatively distinct patient subgroups were identified based on their experiences with the above symptoms (i.e., low levels of all four symptoms (32.9%), low levels of pain and high levels of fatigue (18.0%), high levels of pain and moderate levels of fatigue (42.5%), and high levels of all four symptoms (6.6%). No differences were found among the four subgroups on any demographic, disease, or treatment characteristics. The subgroup of patients who reported high levels of all four symptoms reported the worst functional status and poorest QOL. In conclusion, differences in the symptom experience of oncology outpatients suggest that patients may harbor different phenotypic characteristics (e.g., environmental or physiologic) or genetic determinants for experiencing symptoms that are independent of demographic, disease, and treatment characteristics.

Original languageEnglish (US)
Pages (from-to)162-170
Number of pages9
JournalJournal of Pain and Symptom Management
Volume35
Issue number2
DOIs
StatePublished - Feb 2008

Fingerprint

Outpatients
Quality of Life
Fatigue
Demography
Pain
Sleep
Depression
Karnofsky Performance Status
Israel
Therapeutics
Cluster Analysis
Epidemiologic Studies
Neoplasms

Keywords

  • Cluster analysis
  • depressive symptoms
  • fatigue
  • functional status
  • pain
  • quality of life
  • sleep disturbances
  • symptom clusters

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine
  • Clinical Neurology
  • Neurology
  • Nursing(all)

Cite this

The Symptom Experience of Oncology Outpatients Has a Different Impact on Quality-of-Life Outcomes. / Pud, Dorit; Ben Ami, Sarah; Cooper, Bruce A.; Aouizerat, Bradley E.; Cohen, Dorit; Radiano, Ruth; Naveh, Pnina; Nikkhou-Abeles, Rivka; Hagbi, Vered; Kachta, Orly; Yaffe, Aliza; Miaskowski, Christine.

In: Journal of Pain and Symptom Management, Vol. 35, No. 2, 02.2008, p. 162-170.

Research output: Contribution to journalArticle

Pud, D, Ben Ami, S, Cooper, BA, Aouizerat, BE, Cohen, D, Radiano, R, Naveh, P, Nikkhou-Abeles, R, Hagbi, V, Kachta, O, Yaffe, A & Miaskowski, C 2008, 'The Symptom Experience of Oncology Outpatients Has a Different Impact on Quality-of-Life Outcomes', Journal of Pain and Symptom Management, vol. 35, no. 2, pp. 162-170. https://doi.org/10.1016/j.jpainsymman.2007.03.010
Pud, Dorit ; Ben Ami, Sarah ; Cooper, Bruce A. ; Aouizerat, Bradley E. ; Cohen, Dorit ; Radiano, Ruth ; Naveh, Pnina ; Nikkhou-Abeles, Rivka ; Hagbi, Vered ; Kachta, Orly ; Yaffe, Aliza ; Miaskowski, Christine. / The Symptom Experience of Oncology Outpatients Has a Different Impact on Quality-of-Life Outcomes. In: Journal of Pain and Symptom Management. 2008 ; Vol. 35, No. 2. pp. 162-170.
@article{2394e6fd2cd0476e96baeb60c5dcad47,
title = "The Symptom Experience of Oncology Outpatients Has a Different Impact on Quality-of-Life Outcomes",
abstract = "The aims of this replication study were to determine if subgroups of oncology outpatients receiving active treatment could be identified based on their experience with the symptoms of fatigue, sleep disturbance, depression, and pain; whether patients in these subgroups differed on selected demographic, disease, and treatment characteristics; and if patients in these subgroups differed on functional status and quality of life (QOL). A convenience sample of 228 oncology outpatients was recruited from seven outpatient settings in Israel. Patients completed a demographic questionnaire, a Karnofsky Performance Status score, the Multidimensional Quality of Life Scale-Cancer, the Lee Fatigue Scale, the General Sleep Disturbance Scale, the Center for Epidemiological Studies-Depression Scale, and a numeric rating scale of worst pain intensity. Cluster analysis was used to identify the patient subgroups based on their symptom experience. Four relatively distinct patient subgroups were identified based on their experiences with the above symptoms (i.e., low levels of all four symptoms (32.9{\%}), low levels of pain and high levels of fatigue (18.0{\%}), high levels of pain and moderate levels of fatigue (42.5{\%}), and high levels of all four symptoms (6.6{\%}). No differences were found among the four subgroups on any demographic, disease, or treatment characteristics. The subgroup of patients who reported high levels of all four symptoms reported the worst functional status and poorest QOL. In conclusion, differences in the symptom experience of oncology outpatients suggest that patients may harbor different phenotypic characteristics (e.g., environmental or physiologic) or genetic determinants for experiencing symptoms that are independent of demographic, disease, and treatment characteristics.",
keywords = "Cluster analysis, depressive symptoms, fatigue, functional status, pain, quality of life, sleep disturbances, symptom clusters",
author = "Dorit Pud and {Ben Ami}, Sarah and Cooper, {Bruce A.} and Aouizerat, {Bradley E.} and Dorit Cohen and Ruth Radiano and Pnina Naveh and Rivka Nikkhou-Abeles and Vered Hagbi and Orly Kachta and Aliza Yaffe and Christine Miaskowski",
year = "2008",
month = "2",
doi = "10.1016/j.jpainsymman.2007.03.010",
language = "English (US)",
volume = "35",
pages = "162--170",
journal = "Journal of Pain and Symptom Management",
issn = "0885-3924",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - The Symptom Experience of Oncology Outpatients Has a Different Impact on Quality-of-Life Outcomes

AU - Pud, Dorit

AU - Ben Ami, Sarah

AU - Cooper, Bruce A.

AU - Aouizerat, Bradley E.

AU - Cohen, Dorit

AU - Radiano, Ruth

AU - Naveh, Pnina

AU - Nikkhou-Abeles, Rivka

AU - Hagbi, Vered

AU - Kachta, Orly

AU - Yaffe, Aliza

AU - Miaskowski, Christine

PY - 2008/2

Y1 - 2008/2

N2 - The aims of this replication study were to determine if subgroups of oncology outpatients receiving active treatment could be identified based on their experience with the symptoms of fatigue, sleep disturbance, depression, and pain; whether patients in these subgroups differed on selected demographic, disease, and treatment characteristics; and if patients in these subgroups differed on functional status and quality of life (QOL). A convenience sample of 228 oncology outpatients was recruited from seven outpatient settings in Israel. Patients completed a demographic questionnaire, a Karnofsky Performance Status score, the Multidimensional Quality of Life Scale-Cancer, the Lee Fatigue Scale, the General Sleep Disturbance Scale, the Center for Epidemiological Studies-Depression Scale, and a numeric rating scale of worst pain intensity. Cluster analysis was used to identify the patient subgroups based on their symptom experience. Four relatively distinct patient subgroups were identified based on their experiences with the above symptoms (i.e., low levels of all four symptoms (32.9%), low levels of pain and high levels of fatigue (18.0%), high levels of pain and moderate levels of fatigue (42.5%), and high levels of all four symptoms (6.6%). No differences were found among the four subgroups on any demographic, disease, or treatment characteristics. The subgroup of patients who reported high levels of all four symptoms reported the worst functional status and poorest QOL. In conclusion, differences in the symptom experience of oncology outpatients suggest that patients may harbor different phenotypic characteristics (e.g., environmental or physiologic) or genetic determinants for experiencing symptoms that are independent of demographic, disease, and treatment characteristics.

AB - The aims of this replication study were to determine if subgroups of oncology outpatients receiving active treatment could be identified based on their experience with the symptoms of fatigue, sleep disturbance, depression, and pain; whether patients in these subgroups differed on selected demographic, disease, and treatment characteristics; and if patients in these subgroups differed on functional status and quality of life (QOL). A convenience sample of 228 oncology outpatients was recruited from seven outpatient settings in Israel. Patients completed a demographic questionnaire, a Karnofsky Performance Status score, the Multidimensional Quality of Life Scale-Cancer, the Lee Fatigue Scale, the General Sleep Disturbance Scale, the Center for Epidemiological Studies-Depression Scale, and a numeric rating scale of worst pain intensity. Cluster analysis was used to identify the patient subgroups based on their symptom experience. Four relatively distinct patient subgroups were identified based on their experiences with the above symptoms (i.e., low levels of all four symptoms (32.9%), low levels of pain and high levels of fatigue (18.0%), high levels of pain and moderate levels of fatigue (42.5%), and high levels of all four symptoms (6.6%). No differences were found among the four subgroups on any demographic, disease, or treatment characteristics. The subgroup of patients who reported high levels of all four symptoms reported the worst functional status and poorest QOL. In conclusion, differences in the symptom experience of oncology outpatients suggest that patients may harbor different phenotypic characteristics (e.g., environmental or physiologic) or genetic determinants for experiencing symptoms that are independent of demographic, disease, and treatment characteristics.

KW - Cluster analysis

KW - depressive symptoms

KW - fatigue

KW - functional status

KW - pain

KW - quality of life

KW - sleep disturbances

KW - symptom clusters

UR - http://www.scopus.com/inward/record.url?scp=38349121081&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=38349121081&partnerID=8YFLogxK

U2 - 10.1016/j.jpainsymman.2007.03.010

DO - 10.1016/j.jpainsymman.2007.03.010

M3 - Article

VL - 35

SP - 162

EP - 170

JO - Journal of Pain and Symptom Management

JF - Journal of Pain and Symptom Management

SN - 0885-3924

IS - 2

ER -